SME Central
Home / Moved to Main Board / Shree Ganesh Remedies

Shree Ganesh Remedies: IPO, Share Price and Results Since Listing

Shree Ganesh Remedies moved from BSE SME to the BSE main board. For Q2 FY2027 it reported revenue of INR 23.29 crore (-23.16% on a year earlier) and a profit after tax of INR 1.63 crore.

Key Facts

Moved to
BSE main board (BSE does not publish the date)
Listed on BSE SME
13 October 2017
Symbol
SGRL (BSE code 540737)
Latest close
INR 654 on 13 November 2026

Results Filed With BSE

Consolidated figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
Q2 FY202723.29-23.16%1.631.27after listing31 October 2026
Q1 FY202714.36-41.79%1.120.87after listing12 August 2026
Q4 FY202633.20+35.87%6.274.88after listing14 May 2026
FY2026109.29+0.63%17.7613.83after listing14 May 2026
Q3 FY202621.11–3.092.41after listing23 January 2026
Q2 FY202630.32–4.963.86after listing7 November 2025
Q1 FY202624.67–3.452.68after listing1 August 2025
Q4 FY202524.43–6.595.13after listing19 May 2025
FY2025108.60–23.0717.96after listing19 May 2025

Promoter Holding

Promoter holding has moved from 72.80% on 31 December 2025 to 72.84% on 30 September 2026 (+0.04 percentage points).

As ofPromotersPublic
30 September 202672.84%27.16%
30 June 202672.84%27.16%
31 March 202672.84%27.16%
31 December 202572.80%27.20%

Sources: BSE filings (results XBRL, shareholding pattern, board meetings), BSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.